Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 8 studies | 45% ± 19% | |
GABAergic neuron | 6 studies | 32% ± 16% | |
oligodendrocyte precursor cell | 6 studies | 25% ± 9% | |
amacrine cell | 4 studies | 39% ± 17% | |
retinal bipolar neuron | 4 studies | 45% ± 20% | |
GABAergic amacrine cell | 3 studies | 41% ± 15% | |
ON-bipolar cell | 3 studies | 35% ± 14% | |
rod bipolar cell | 3 studies | 73% ± 26% | |
interneuron | 3 studies | 32% ± 13% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 6 studies | 35% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 71% | 322.19 | 1884 / 2642 | 18% | 0.71 | 126 / 705 |
adrenal gland | 24% | 50.66 | 63 / 258 | 62% | 5.48 | 142 / 230 |
bladder | 33% | 42.86 | 7 / 21 | 3% | 0.08 | 13 / 504 |
prostate | 29% | 35.52 | 70 / 245 | 0% | 0 | 0 / 502 |
adipose | 27% | 42.81 | 326 / 1204 | 0% | 0 | 0 / 0 |
intestine | 26% | 12.03 | 247 / 966 | 1% | 0.01 | 4 / 527 |
breast | 19% | 12.80 | 87 / 459 | 1% | 0.03 | 7 / 1118 |
lung | 9% | 7.44 | 53 / 578 | 3% | 0.08 | 35 / 1155 |
stomach | 9% | 4.04 | 34 / 359 | 1% | 0.02 | 4 / 286 |
esophagus | 6% | 2.33 | 86 / 1445 | 3% | 0.05 | 6 / 183 |
skin | 4% | 2.09 | 81 / 1809 | 4% | 0.08 | 19 / 472 |
uterus | 4% | 2.34 | 7 / 170 | 3% | 0.12 | 16 / 459 |
ovary | 6% | 1.94 | 11 / 180 | 1% | 0.01 | 4 / 430 |
kidney | 6% | 2.04 | 5 / 89 | 1% | 0.02 | 5 / 901 |
thymus | 0% | 0.04 | 1 / 653 | 4% | 0.16 | 23 / 605 |
heart | 3% | 2.36 | 29 / 861 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 2% | 0.06 | 4 / 178 |
eye | 0% | 0 | 0 / 0 | 1% | 0.03 | 1 / 80 |
spleen | 1% | 0.35 | 2 / 241 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0.01 | 2 / 406 |
blood vessel | 0% | 0.09 | 3 / 1335 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.04 | 1 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.09 | 1 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0010389 | Biological process | regulation of G2/M transition of mitotic cell cycle |
GO_0071805 | Biological process | potassium ion transmembrane transport |
GO_0009986 | Cellular component | cell surface |
GO_0005886 | Cellular component | plasma membrane |
GO_0008076 | Cellular component | voltage-gated potassium channel complex |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005516 | Molecular function | calmodulin binding |
GO_0005249 | Molecular function | voltage-gated potassium channel activity |
GO_0044325 | Molecular function | transmembrane transporter binding |
Gene name | KCNH5 |
Protein name | Potassium voltage-gated channel subfamily H member 5 (Ether-a-go-go potassium channel 2) (hEAG2) (Voltage-gated potassium channel subunit Kv10.2) KCNH5 protein |
Synonyms | EAG2 |
Description | FUNCTION: Pore-forming (alpha) subunit of voltage-gated potassium channel. Elicits a non-inactivating outward rectifying current. Channel properties may be modulated by cAMP and subunit assembly. |
Accessions | ENST00000420622.6 [Q8NCM2-2] ENST00000322893.12 [Q8NCM2-1] Q8NCM2 ENST00000394968.2 [Q8NCM2-3] Q86XI1 |